The Protective Effect of Dapagliflozin Against Contrast-Induced Nephropathy After Percutaneous Coronary Catheterization in Patients Moderate to High-Risk for CIN. VER [Internet]. 2025 Nov. 1 [cited 2026 Apr. 28];8(5s):154-61. Available from: https://verjournal.com/index.php/ver/article/view/448